Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576271
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
A Study of GSK4527363 in Healthy Participants Systemic Lupus Erythematosus SLE Participants and Healthy Chinese and Japanese Participants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 First-time-in-human Three-part Study to Evaluate the Safety Tolerability Pharmacokinetics Pharmacodynamics and Immunogenicity of GSK4527363 in Healthy Participants Part A Participants With Active Systemic Lupus Erythematosus Part B and Healthy Participants of Chinese and Japanese Descent Part C
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the safety tolerability pharmacokinetics pharmacodynamics and immunogenicity of GSK4527363 in healthy participants Part A participants with active SLE Part B and healthy participants of Chinese and Japanese descent Part C
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None